Does BELANTAMAB MAFODOTIN Cause Keratopathy? 788 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 788 reports of Keratopathy have been filed in association with BELANTAMAB MAFODOTIN (Blenrep). This represents 34.4% of all adverse event reports for BELANTAMAB MAFODOTIN.
788
Reports of Keratopathy with BELANTAMAB MAFODOTIN
34.4%
of all BELANTAMAB MAFODOTIN reports
181
Deaths
79
Hospitalizations
How Dangerous Is Keratopathy From BELANTAMAB MAFODOTIN?
Of the 788 reports, 181 (23.0%) resulted in death, 79 (10.0%) required hospitalization, and 2 (0.3%) were considered life-threatening.
Is Keratopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BELANTAMAB MAFODOTIN. However, 788 reports have been filed with the FAERS database.
What Other Side Effects Does BELANTAMAB MAFODOTIN Cause?
Visual acuity reduced (708)
Death (499)
Plasma cell myeloma (380)
Dry eye (359)
Night blindness (317)
Photophobia (183)
Foreign body sensation in eyes (151)
Vision blurred (134)
Ocular toxicity (94)
Punctate keratitis (91)
What Other Drugs Cause Keratopathy?
AMIODARONE (76)
METHOTREXATE (57)
DEXAMETHASONE (48)
DICLOFENAC (42)
HYALURONATE (42)
PREDNISOLONE (42)
CHLORAMPHENICOL (37)
CYCLOPENTOLATE (37)
ADALIMUMAB (35)
MIRVETUXIMAB SORAVTANSINE-GYNX (35)
Which BELANTAMAB MAFODOTIN Alternatives Have Lower Keratopathy Risk?
BELANTAMAB MAFODOTIN vs BELANTAMAB MAFODOTIN-BLMF
BELANTAMAB MAFODOTIN vs BELATACEPT
BELANTAMAB MAFODOTIN vs BELIMUMAB
BELANTAMAB MAFODOTIN vs BELINOSTAT
BELANTAMAB MAFODOTIN vs BELUMOSUDIL